TABLE 1.
The four outcome groups at three-year follow-up in relation to the situation at the start of treatment contact.
| Descriptives | Total | SUP/no MHP | No SUP/MHP | SUP/MHP | no SUP/no MHP |
|---|---|---|---|---|---|
| N=451 | n=69 | n=90 | n=58 | n=234 | |
| % | % | % | % | % | |
| Sex | |||||
| Girls | 29 | 7 | 40 | 38 | 30 |
| Boys | 71 | 93 | 60 | 62 | 70 |
| Age (mean) | 17 | 17 | 17 | 17 | 17 |
| Living with parents | 72 | 84 | 74 | 60 | 71 |
| Low level of education for parents (primary school) | 4 | 10 | 2 | - | 4 |
| Reading and writing difficulties | 19 | 28 | 18 | 29 | 14 |
| Upper secondary school eligibility | 68 | 52 | 74 | 67 | 71 |
| Lack of employment | 18 | 17 | 20 | 19 | 18 |
| Serious conflicts with parents | 36 | 29 | 36 | 35 | 39 |
| Arrested for crime | 61 | 78 | 48 | 60 | 62 |
| Hazardous Alcohol Consumption (AUDIT) | 48 | 36 | 50 | 50 | 50 |
| Primary drug | |||||
| Alcohol | 14 | 6 | 18 | 14 | 15 |
| Cannabis | 77 | 86 | 71 | 81 | 75 |
| Other drugs | 9 | 9 | 11 | 5 | 10 |
| Primairy drug use requency 2–3 days/week or more | 49 | 55 | 38 | 57 | 49 |
| Polydrug use | 38 | 33 | 37 | 47 | 38 |
| Anxiety or worry | 49 | 38 | 63 | 57 | 46 |
| Concentration problems | 58 | 52 | 67 | 69 | 55 |
| Suicide thoughts | 8 | 7 | 8 | 9 | 8 |
| Eating disorder | 8 | 6 | 9 | 9 | 8 |
| Self-harm behavior | 7 | 1 | 4 | 12 | 8 |
| Medication for Mental Health Problems | 21 | 9 | 39 | 40 | 13 |
TABLE 2.
Descriptives of outcome indicators: Mental Health Problems (MHP) and Substance Use Problems (SUP) three years after initiated treatment.
| Total | Girls | Boys | |||
|---|---|---|---|---|---|
| N=451 | n=131 | n=320 | |||
| % | % | % | Chi-2 | p-value | |
| Indication of mental health problems (MHP) | 33 | 44 | 28 | 10.47 | 0.00** |
| Outpatient treatment, psychiatry | 22 | 30 | 18 | 7.60 | 0.00** |
| In-patient treatment, psychiatry | 5 | 6 | 4 | 0.56 | 0.45 |
| Medical treatment, mental illness | 29 | 41 | 24 | 12.74 | 0.00** |
| Indications of Substance use problems (SUP) | 28 | 20 | 31 | 5.48 | 0.02* |
| Outpatient substance use care | 16 | 17 | 15 | 0.30 | 0.59 |
| Inpatient substance use care | 7 | 5 | 7 | 0.55 | 0.46 |
| Medication for alcohol or drug use problems | 1 | 1 | 1 | 0.02 | 0.88 |
| Compulsory care | 2 | 2 | 2 | 0.22 | 0.64 |
| Substance use–related criminality | 15 | 5 | 19 | 13.92 | 0.00** |
TABLE 3.
Categories of psychiatric diagnoses according to ICD-10 during follow-up three years after initiated treatment for the outcome groups. Percentage distribution.
| Total | SUP/no MHP | no SUP/MHP | SUP/MHP no | SUP/no MHP | |||
|---|---|---|---|---|---|---|---|
| N=451 | n=69 | n=90 | n=58 | n=234 | |||
| % | % | % | % | % | Chi-2 | p - value | |
| Diagnostic category | 463.514 | <0.001 | |||||
| Assesment/observation | 4 | 0 | 12 | 10 | 0 | ||
| Anxiety/depression | 14 | 0 | 43 | 40 | 0 | ||
| Neurodevelopmental disorders | 12 | 0 | 39 | 35 | 0 | ||
| Psychosis/bipolar etc | 2 | 0 | 6 | 16 | 0 | ||
| No diagnosis | 67 | 100 | 0 | 0 | 100 |
TABLE 4.
Bivariate association and logistic regression analysis of risk factors in relation to the outcome group Mental Health Problems (MHP) and Substance Use Problems (SUP) three years after initiated treatment. Odds ratio and confidence interval are reported (N=451).
| Psychosocial risk factors | no SUP/MHP | SUP/MHP | ||||
|---|---|---|---|---|---|---|
| Bivariate association | Model 1 | Model 2 | Bivariate association | Model 3 | Model 4 | |
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| 1. Lack of occupation | 1.16 (0.65–2.08) | 0.92 (0.50–1.69) | 1.11 (0.58–2.16) | 1.06 (.52–2.15) | .90 (.43–1.91) | .97 (.44–2.12) |
| 2. Problems at school | 2.75 (1.41–5.39)** | 2.51 (1.24–5.04)* | 2.53 (1.24–5.16)* | 1.15 (.60–2.22) | .94 (.47–1.91) | .91 (.45–1.85) |
| 3. Placement in foster care/residential home | 0.82 (0.45–1.50) | 0.68 (0.36–1.26) | 0.70 (0.37–1.32) | 2.17 (1.19–3.98)* | 2.02 (1.07–3.80)* | 2.00 (1.06–3.76)* |
| 4. Problems in childhood environment | 1.29 (0.80–2.08) | 1.00 (0.58–1.71) | 1.08 (0.62–1.88) | 1.74 (.96–3.18) | 1.48 (.76–2.86) | 1.47 (.76–2.85) |
| 5. Early drug debut | 1.36 (0.80–2.32) | 1.34 (0.76–2.35) | 1.18 (0.66–2.10) | 1.40 (.75–2.62) | 1.17 (.61–2.26) | 1.17 (.60–2.27) |
| 6. Delinquent peers | 1.09 (0.62–1.93) | 0.98 (0.55–1.78) | 1.24 (0.67–2.31) | .93 (.46–1.88) | .84 (.41–1.73) | .82 (.39–1.72) |
| 7. Exposure to violence | 1.43 (0.88–2,33) | 1.11 (0.64–1.91) | 1.09 (0.62–1.93) | 1.48 (.82–2.67) | 1.18 (.62–2.28) | 1.16 (.59–2.25) |
| 8. Depression | 1.99 (1.24–3.19)** | 1.81 (1.07–3.07)* | 2.00 (1.14–3.50)* | 1.30 (.73–2.29) | 1.05 (.55–1.99) | 1.01 (.52–1.96) |
| 9. Violent behavior | 1.19 (0.69–2.05) | 0.84 (0.47–1.51) | 0.79 (0.43–1.44) | 1.42 (.76–2.66) | 1.40 (.71–2.76) | 1.43 (.73–2.82) |
| 10. Traumatic events | 1.40 (0.87–2.25) | 1.07 (0.63–1.82) | 1.01 (0.58–1.74) | 1.27 (.72–2.24) | .96 (.51–1.81) | .93 (.49–1.77) |
| Covariates | ||||||
| Sex | 1.72 (1.03–2.90)* | 1.46 (0.80–2.69) | ||||
| Age | 1.00 (0.90–1.11) | 0.97 (0.85–1.10) | ||||
| Primary drug use frequency at intake | 0.44 (0.26–0.75)** | 1.43 (0.78–2.62) | ||||
Note. Model 1 and Model 3 includes risk factors 1–10 and Model 2 and Model 4 includes risk factors 1–10 but also sex, age and primary drug use frequency at intake. Model 1: χ2 [10] = 18.73, p = 0.04, Nagelkerke’s quasi R2 = 0.06. Model 2: χ2 [13] = 32.31, p = 0.00, Nagelkerke’s quasi R2 = 0.11. Modell 3: χ2 [10] = 10.12, p = 0.43, Nagelkerke’s quasi R2 = 0.04. Modell 4: χ2 [13] = 13.32, p = 0.42, Nagelkerke’s quasi R2 = 0.05.
TABLE 5.
Odds ratios and confidence intervals for the association between adolescent cumulative risk in relation to the outcome group Mental Health Problems (MHP) and Substance Use Problems (SUP) three years after initiated treatment (N=451).
| Cumulative risk | no SUP/MHP | SUP/MHP |
|---|---|---|
| OR (95 % CI) | OR (95 % CI) | |
| Model 5 | Model 7 | |
| 0–2 risk factors (31%) Ref | 1 | 1 |
| 3–5 risk factors (49%) | 1.85 (1.03–3.34)* | 1.69 (0.84–3.43) |
| 6–10 risk factors (21%) | 2.53 (1.29–4.97)** | 2.25 (1.01–5.00)* |
| Model 6 | Model 8 | |
| 0–2 risk factors (31%) Ref | 1 | 1 |
| 3–5 risk factors (49%) | 1.93 (1.05–3.55)* | 1.61 (0.78–3.30) |
| 6–10 risk factors (21%) | 2.74 (1.33–5.64)** | 2.09 (0.89–4.90) |
| Covariates | ||
| Sex | 1.78 (1.08–2.93)* | 1.45 (0.81–2.60) |
| Age | 1.02 (0.92–1.12) | 0.95 (0.85–1.07) |
| Primary drug use frequency at intake | 0.47 (0.28–0.78)** | 1.09 (0.92–1.29) |
Model 5 and 7 includes the level of cummulative risk, Model 6 and Model 8 includes both the level of cumulative risk but also includes sex, age and primary drug use frequency at intake. Model 5: χ2 [2] = 7.98, p = 0.02, Nagelkerke’s quasi R2 = 0.03. Model 6: χ2 [5] = 21.39, p = 0.00, Nagelkerke’s quasi R2 = 0.07. Model 7: χ2 [2] = 4.24, p = 0.12, Nagelkerke’s quasi R2 = 0.02. Model 8:(χ2 [5] = 7.09, p = 0.21, Nagelkerke’s quasi R2 = 0.03.